The application of highly selective DRD4 agonists could significantly improve the cognitive ability of ADHD model rats; moreover, it did not increase the risk of substance abuse compared with psychostimulant therapy [44, 45]. The gene discussed is DRD4; the disease is attention deficit-hyperactivity disorder.